Anticonvulsants
Anticonvulsants
Healthplan Pharma (India) Pvt. Ltd. offers a focused range of anticonvulsant medicines formulated to support the management of seizure disorders, epilepsy, and related neurological conditions. The portfolio includes immediate-release and controlled-release formulations, providing flexibility for individualized dosing and long-term therapy.
Divalproex Sodium (Extended Release)
Dova ER® 250 / 500 / 750
- Tablets
(Divalproex Sodium 250 mg / 500 mg / 750 mg)
Formulated to support stable plasma levels and improved treatment adherence in seizure management.
Sodium Valproate + Valproic Acid (Controlled Release)
Sovam CR® 200 / 300 / 500
- Tablets
(Sodium Valproate IP 333 / 200 / 133.5 mg + Valproic Acid USP 145 / 87 / 58 mg)
Controlled-release combination designed for sustained anticonvulsant effect.
Clonazepam
Halopam® 0.25 MD
- Tablets
(Clonazepam USP 0.25 mg)
Halopam® 0.5 / 1 / 2
- Tablets
(Clonazepam 0.5 mg / 1 mg / 2 mg)
Used as adjunctive therapy in seizure disorders and related neurological indications.
Clobazam
Cloma® 5 / 10
- Tablets
(Clobazam 5 mg / 10 mg)
Supports seizure control as monotherapy or adjunctive treatment.
Sodium Phenytoin
Toin® 100
- Tablets
(Sodium Phenytoin 100 mg)
A well-established anticonvulsant option for seizure management.